概览
September 23-24: Conference
Clinical trial information transparency is taking on new dimensions. Clinical trial sponsors and academia are facing a host of new registration requirements in the US, EU, and elsewhere. With evolving requirements comes new challenges, creating additional opportunities for knowledge-sharing and necessitating more interaction with peers. This conference will provide critical and timely information relating to global clinical trial disclosure and data transparency from those on the front lines.
While we develop our 2024 agenda, please take a moment to review the 2021 final agenda.
Need Approval in Order to Attend?
Download and fill out our Justification Letter to demand to supervisor why this is a must-attend event.
Participant Testimonials
Thanks for organizing such a nice conference on CTD and Trial Transparency. It was my first experience attending the DIA conference and I learnt new initiatives taken across industry.” – Ravi Jogai, Associate Director - Syneos Health (Seasoned Clinical Research Professional)
Featured
Want to learn more about Global Clinical Trial Disclosure and Data Transparency Conference? You've come to the right site!
项目委员会
-
Robert Paarlberg, MS Principal
Paarlberg & Associates LLC, United States -
Kelly Coulbourne, MS Director, Clinical Trial Disclosure and Data Transparency
Pfizer Inc, United States -
Scott Feiner Senior Manager, Trial Disclosure
AbbVie, United States -
Francine Lane, MBA Senior Director of Product Management
Citeline, United States -
Pritibha Singh, MBA, MSc Senior Manager, Corporate Affairs Analytics & Insights
Novartis AG, Switzerland -
Merete Joergensen, MBA, MSc Clinical Disclosure and Transparency Expert, Former EFPIA, CREG Clinical Trials
Merete-J Consulting CVR: 34920818, Denmark